Evidence map›Paper›PMID 37561246›Full record

Trial reportJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2025

Targeted ablation of epicardial ganglionated plexi during cardiac surgery with pulsed field electroporation (NEURAL AF).

Daniel R Musikantow, Vivek Y Reddy, Ivo Skalsky, Tamaz Shaburishvili, Martin van Zyl, Barry O'Brien, Ken Coffey, John Reilly, Petr Neuzil, Samuel Asirvatham and 1 more

Registry-linked trialAbstract readClinical Trial
In one paragraph

Trial report in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04775264 (Safety and Feasibility of Atrial Deganglionation as Adjunctive Therapy for Atrial Fibrillation), which is not on this map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04775264 nacompletednot on this map

Safety and Feasibility of Atrial Deganglionation as Adjunctive Therapy for Atrial Fibrillation

TypeinterventionalSponsorAtrian Medical Ltd.Ran2021 to 2023Enrolled24ConditionsAtrial FibrillationArmsPulsed Electric Field Ablation
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Peri-procedure and Mid-Long Term Effects of Pulsed Field Ablation vs. Thermal Ablation (Cryo- or Radiofrequency) on Autonomic Nervous System Function in Atrial Fibrillation: A Systematic and Quantitative Pooled-Analysis with Potential Implications for Patient Selection (The PULSE-COLD-HEAT-ANS Collaboration).Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Pooled it
  2. Review
  3. Article
  4. Short-term deceleration capacity: a novel non-invasive indicator of parasympathetic activity in patients undergoing pulmonary vein isolation.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2025
    Article
  5. Contemporary Trends in Pulsed Field Ablation for Cardiac Arrhythmias.Journal of cardiovascular development and disease · 2024
    Review
  6. Review
  7. State-of-the-art pulsed field ablation for cardiac arrhythmias: ongoing evolution and future perspective.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Review
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Daniel R MusikantowHelmsley Electrophysiology Center, Icahn School of Medicine at Mount Sinai, Box 1030, One Gustave L. Levy Place, New York, NY, 10029, USA.
Vivek Y ReddyHelmsley Electrophysiology Center, Icahn School of Medicine at Mount Sinai, Box 1030, One Gustave L. Levy Place, New York, NY, 10029, USA. vivek.reddy@mountsinai.org.
Ivo SkalskyHomolka Hospital, Prague, Czech Republic.
Tamaz ShaburishviliTbilisi Heart and Vascular Clinic, Tbilisi, Georgia.
Martin van ZylRoyal Jubilee Hospital, Victoria, BC, Canada.
Barry O'BrienAtriAN Medical, Galway, Ireland.
Ken CoffeyAtriAN Medical, Galway, Ireland.
John ReillyAtriAN Medical, Galway, Ireland.
Petr NeuzilHomolka Hospital, Prague, Czech Republic.
Samuel AsirvathamMayo Clinic, Rochester, MN, USA.
Joris R de GrootUniversity Medical Center, Amsterdam, The Netherlands.

Funding

Horizon 2020 879499
6 · The paper itself

Abstract

backgroundModulation of the cardiac autonomic nervous system (ANS) is a promising adjuvant therapy in the treatment of atrial fibrillation (AF). In pre-clinical models, pulsed field (PF) energy has the advantage of selectively ablating the epicardial ganglionated plexi (GP) that govern the ANS. This study aims to demonstrate the feasibility and safety of epicardial ablation of the GPs with PF during cardiac surgery with a primary efficacy outcome of prolongation of the atrial effective refractory period (AERP).

methodsIn a single-arm, prospective analysis, patients with or without a history of AF underwent epicardial GP ablation with PF during coronary artery bypass grafting (CABG). AERP was determined immediately pre- and post- GP ablation to assess cardiac ANS function. Holter monitors were performed to determine rhythm status and heart rate variability (HRV) at baseline and at 1-month post-procedure.

resultsOf 24 patients, 23 (96%) received the full ablation protocol. No device-related adverse effects were noted. GP ablation resulted in a 20.7 ± 19.9% extension in AERP (P < 0.001). Post-operative AF was observed in 7 (29%) patients. Holter monitoring demonstrated an increase in mean heart rate (74.0 ± 8.7 vs. 80.6 ± 12.3, P = 0.01). There were no significant changes in HRV. There were no study-related complications.

conclusionsThis study demonstrates the safety and feasibility of epicardial ablation of the GP using PF to modulate the ANS during cardiac surgery. Large, randomized analyses are necessary to determine whether epicardial PF ablation can offer a meaningful impact on the cardiac ANS and reduce AF.

trial registrationClinical trial registration: NCT04775264.

Indexed as

Atrial FibrillationCatheter AblationCoronary Artery BypassElectroporationGanglia, AutonomicPericardiumAgedElectrocardiography, AmbulatoryFeasibility StudiesFemaleHumansMaleMiddle AgedProspective StudiesTreatment OutcomeAtrial fibrillationCardiac autonomic nervous systemPost-operative atrial fibrillationPulsed field ablation

Identifiers

PMID37561246
PMCPMC12043773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.